Apollomics (APLM) Payables (2023 - 2025)

Apollomics (APLM) posted quarterly Payables of $124000.0 for Q4 2025, up 21.57% year-on-year from $102000.0 in Q4 2024, and down 74.49% on a QoQ basis from $486000.0 in Q2 2025.

Apollomics (APLM) Payables (2023 - 2025) Analysis & Trends

Apollomics (APLM) has reported Payables for 3 consecutive years, with $124000.0 the latest figure, recorded in Q4 2025.

  • Quarterly Payables rose 21.57% year-over-year to $124000.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $124000.0 (up 21.57% YoY) and the FY2025 annual result came in at $124000.0, up 21.57% from the prior year.
  • Payables slipped to $124000.0 in Q4 2025 per APLM's latest filing, from $486000.0 in the prior quarter.
  • Over the last five years, Payables for APLM reached as high as $4.2 million in Q4 2023 and fell as low as $102000.0 in Q4 2024.
  • A 3-year average of $1.6 million and a median of $716500.0 in 2023 frame the typical range for Payables.
  • The largest YoY upside for Payables was 270.43% in 2024 against a maximum downside of 97.59% in 2024.
  • Year by year, Payables stood at $4.2 million in 2023, then slumped by 97.59% to $102000.0 in 2024, then grew by 21.57% to $124000.0 in 2025.
  • According to Business Quant data, Payables over the past three periods registered $124000.0, $486000.0, and $102000.0 for Q4 2025, Q2 2025, and Q4 2024 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Payables (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - 5.74 Mn
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - 10.62 Mn
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 423.55 Mn
4 NuCana 279.75 Bn 279.75 Bn - 694,346.76
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 489.30 Mn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 1.03 Bn
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn 1.52 Bn
9 Revolution Medicines 37.78 Bn 37.78 Bn - 80.54 Mn
10 Apollomics 2.66 Bn 2.66 Bn - 124,000.00

Historic Data

Download Data
DateValue
Dec 31, 2025 124,000.00
Jun 30, 2025 486,000.00
Dec 31, 2024 102,000.00
Jun 30, 2024 3.51 Mn
Dec 31, 2023 4.24 Mn
Jun 30, 2023 947,000.00